Status:
UNKNOWN
The Efficacy of EMDR in Youngsters With Autism
Lead Sponsor:
Karakter Kinder- en Jeugdpsychiatrie
Collaborating Sponsors:
Fonds Psychische Gezondheid
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
12-21 years
Phase:
NA
Brief Summary
Rationale: Currently, for youngsters there is no treatment available that directly targets the core symptoms of autism. EMDR is hypothesized to improve the core symptoms of ASD by reducing the general...
Eligibility Criteria
Inclusion
- Diagnosed with ASD (with or without comorbid psychiatric disorders, except PTSD and anxiety disorders)
- Full-scale IQ of 80 or more
- Able to understand and speak Dutch
Exclusion
- Receiving other treatments than medication on a stable dosage.
- PTSD or other comorbid psychiatric disorders that require immediate and continuous treatment.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03467464
Start Date
December 1 2017
End Date
December 1 2018
Last Update
March 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karakter kinder- en jeugdpsychiatrie
Nijmegen, Gelderland, Netherlands, 6525 GC